Acto, a Toronto, Canada-based education and engagement platform for life sciences companies, raised $11.5m in Series A funding.
The round was led by Resolve Growth Partners.
The company intends to use the funds to expand operations and its business reach.
Led by CEO Parth Khanna, Acto provides an education and engagement platform for life sciences companies. The company uses AI-powered mobile experiences and agency partnerships to educate and engage field reps, physicians and patients, while giving senior commercial and clinical leaders real-time insights.
Acto currently works with more than 60 drug and medical device manufacturers on brand strategies and outreach tactics.